Relationship between tumoral marker 15.3 dosage and evolution of breast cancer

Women treated of breast cancer have survived more in the last decades. However, the detection of relapse has been the major difficult in order to establish treatment in an early stage. This article is a continuation of a study about the utilization of the tumor marker CA 15.3 in the follow-up of patients treats of breast cancer in the Hospital Naval Marcilio Dias. Thirty-eight women were evaluated in order to compare the results of the test with the evolution of the disease. The study shows. CA 15.3 as an useful test to follow-up treated women, instead of the low sensitivity (40%) encountered in this research, different from the results of the literature. The specificity and the predictive valors were high. The positivity of the test was higher when the lung and the liver were compromised. (author)